37 related articles for article (PubMed ID: 17270549)
1. Isolated liver transplantation in infants with end-stage liver disease associated with short bowel syndrome.
Horslen SP; Sudan DL; Iyer KR; Kaufman SS; Iverson AK; Fox IJ; Shaw BW; Langnas AN
Ann Surg; 2002 Mar; 235(3):435-9. PubMed ID: 11882766
[TBL] [Abstract][Full Text] [Related]
2. Predictors of failure of fish-oil therapy for intestinal failure-associated liver disease in children.
Nandivada P; Baker MA; Mitchell PD; O'Loughlin AA; Potemkin AK; Anez-Bustillos L; Carlson SJ; Dao DT; Fell GL; Gura KM; Puder M
Am J Clin Nutr; 2016 Sep; 104(3):663-70. PubMed ID: 27510535
[TBL] [Abstract][Full Text] [Related]
3. A CARD9 polymorphism is associated with decreased likelihood of persistent conjugated hyperbilirubinemia in intestinal failure.
Burghardt KM; Avinashi V; Kosar C; Xu W; Wales PW; Avitzur Y; Muise A
PLoS One; 2014; 9(1):e85915. PubMed ID: 24465786
[TBL] [Abstract][Full Text] [Related]
4. Risks and benefits of prophylactic cyclic parenteral nutrition in surgical neonates.
Nghiem-Rao TH; Cassidy LD; Polzin EM; Calkins CM; Arca MJ; Goday PS
Nutr Clin Pract; 2013 Dec; 28(6):745-52. PubMed ID: 24107391
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
[TBL] [Abstract][Full Text] [Related]
6. Isolated liver transplantation in infants with end-stage liver disease due to short bowel syndrome.
Botha JF; Grant WJ; Torres C; Iverson AK; Sudan DL; Shaw BW; Langnas AN
Liver Transpl; 2006 Jul; 12(7):1062-6. PubMed ID: 16710856
[TBL] [Abstract][Full Text] [Related]
7. Neonatal short bowel syndrome: a cohort study.
Wales PW; de Silva N; Kim JH; Lecce L; Sandhu A; Moore AM
J Pediatr Surg; 2005 May; 40(5):755-62. PubMed ID: 15937809
[TBL] [Abstract][Full Text] [Related]
8. Isolated liver and multivisceral transplantation for total parenteral nutrition-related end-stage liver disease.
Nathan JD; Rudolph JA; Kocoshis SA; Alonso MH; Ryckman FC; Tiao GM
J Pediatr Surg; 2007 Jan; 42(1):143-7. PubMed ID: 17208555
[TBL] [Abstract][Full Text] [Related]
9. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome.
Diamond IR; Sterescu A; Pencharz PB; Kim JH; Wales PW
J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):209-15. PubMed ID: 19179884
[TBL] [Abstract][Full Text] [Related]
10. The use of conjugated hyperbilirubinemia greater than 100 micromol/L as an indicator of irreversible liver disease in infants with short bowel syndrome.
Nasr A; Avitzur Y; Ng VL; De Silva N; Wales PW
J Pediatr Surg; 2007 Feb; 42(2):359-62. PubMed ID: 17270549
[TBL] [Abstract][Full Text] [Related]
11. Isolated liver transplantation in pediatric short bowel syndrome: is there a role?
Diamond IR; Wales PW; Grant DR; Fecteau A
J Pediatr Surg; 2006 May; 41(5):955-9. PubMed ID: 16677892
[TBL] [Abstract][Full Text] [Related]
12. Citrulline and the gut.
Curis E; Crenn P; Cynober L
Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):620-6. PubMed ID: 17693747
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
